Meral TUNCER, Edip Güvenç ÇEKİÇ, Güray SOYDAN, Dilek ERTOY BAYDAR, Sebile GÜLER ÇEKİÇ

Vascular responses of aortic, renal, and uterine arteries in suramin-induced preeclampsia-like syndrome in rats

Background/aim: Suramin is a potent angiogenesis inhibitor in rodents and attenuates placental development in rat pregnancy. Weaimed to produce preeclampsia-like syndrome by suramin administration in rats and to investigate the functional responses in aortic,renal, and uterine arteries.Materials and methods: Pregnant and nonpregnant wistar rats received suramin (100 mg/kg, intraperitoneal) or equal volume of salineon days 10 and 11. Blood pressures of rats were observed daily. On the day 20, rats were executed. Protein levels in urine were measuredand fetuses, placentas, and kidneys were weighted and evaluated. Thoracic aorta, renal, and uterine arteries were removed for functionalstudies.Results: Increased blood pressures and proteinuria were detected in suramin-given pregnant rats. Pathological examination of kidneysshowed an acute tubular injury after suramin injection. Numbers and weights of fetuses and placentas were reduced in suramin-givenpregnant rats. In functional studies, endothelial dysfunction occurred in uterine and renal arteries but not in the aorta. In this study, weshowed that preeclampsia-like syndrome occurred in suramin-given rats.Conclusion: Our findings, which show that endothelial dysfunction occurred in uterine and renal arteries but not in the aorta, areconsistent with the human findings of microvascular changes in preeclampsia.

PDF

___

Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Kirmeyer S. Births: final data for 2004. Natl Vital Stat Rep 2006; 55: 1-101.
Ghulmiyyah L, Sibai B. Maternal mortality from preeclampsia/ eclampsia. Semin Perinatol 2012; 36: 56-59.
Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005; 308: 1592-1594.
McNally R, Alqudah A, Obradovic D, McClements L. Elucidating the pathogenesis of pre-eclampsia using in vitro models of spiral uterine artery remodelling. Curr Hypertens Rep 2017; 19: 93.
Brosens IA, Robertson WB, Dixon HG. The role of the spiral arteries in the pathogenesis of preeclampsia. Obs Gynecol Annu 1972; 1: 177-191.
Redman CW. Current topic: pre-eclampsia and the placenta. Placenta 1991; 12: 301-308.
Roberts JM, Taylor RN, Goldfien A. Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hypertens 1991; 4: 700-708.
Redman CW, Sargent IL. Pre-eclampsia, the placenta and the maternal systemic inflammatory response—a review. Placenta 2003; 24 Suppl A: 21-27.
Maynard S, Epstein FH, Karumanchi SA. Preeclampsia and angiogenic imbalance. Annu Rev Med 2008; 59: 61-78.
Visser W, Wallenburg HC. Central hemodynamic observations in untreated preeclamptic patients. Hypertension 1991; 17: 1072-1077.
Pijnenborg R, Anthony J, Davey DA, Rees A, Tiltman A, Vercruysse L, van Assche A. Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obs Gynaecol 1991; 98: 648-655.
Dechend R, Luft FC. Angiogenesis factors and preeclampsia. Nat Med 2008; 14: 1187-1188.
Verdonk K, Saleh L, Lankhorst S, Smilde JEI, van Ingen MM, Garrelds IM, Friesema EC, Russcheret H, van den Meiracker AH, Visser W et al. Association studies suggest a key role for endothelin-1 in the pathogenesis of preeclampsia and the accompanying renin-angiotensin-aldosterone system suppression. Hypertension 2015; 65: 1316-1323.
Jankowski M. Angiogenesis inhibition and preeclampsia. J Hypertens 2009; 27: 707-708.
Carlström M, Wentzel P, Skøtt O, Persson AE, Eriksson UJ. Angiogenesis inhibition causes hypertension and placental dysfunction in a rat model of preeclampsia. J Hypertens 2009; 27: 829-837.
Nash P, Wentzel P, Lindeberg S, Naessen T, Jansson L, Olovsson M, Eriksson UJ. Placental dysfunction in suramin-treated rats–a new model for pre-eclampsia. Placenta 2005; 26: 410- 418.
Bocci G, Danesi R, Benelli U, Innocenti F, Di Paolo A, Fogli S, Del Tacca M. Inhibitory effect of suramin in rat models of angiogenesis in vitro and in vivo. Cancer Chemother Pharmacol 1999; 43: 205-212.
Taylor RN, de Groot CJ, Cho YK, Lim KH. Circulating factors as markers and mediators of endothelial cell dysfunction in preeclampsia. Semin Reprod Endocrinol 1998; 16: 17-31.
Turgut NH, Temiz TK, Bagcivan I, Turgut B, Gulturk S, Karadas B. The effect of sildenafil on the altered thoracic aorta smooth muscle responses in rat pre-eclampsia model. Eur J Pharmacol 2008; 589: 180-187.
Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 1977; 41: 19-26.
Sunderland N, Hennessy A, Makris A. Animal models of preeclampsia. Am J Reprod Immunol 2011; 65: 533-541.
Yallampalli C, Garfield RE. Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am J Obs Gynecol 1993; 169: 1316-1320.
Kashif W, Siddiqi N, Dincer AP, Dincer HE, Hirsch S. Proteinuria: how to evaluate an important finding. Cleve Clin J Med 2003; 70: 535-537, 541-544, 546-547.
Duke BO. The effects of drugs on Onchocerca volvulus. 3. Trials of suramin at different dosages and a comparison of the brands Antrypol, Moranyl and Naganol. Bull World Heal Organ 1968; 39: 157-167.
Khalil RA, Granger JP. Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models. Am J Physiol Regul Integr Comp Physiol 2002; 283: R29-45.
Bakrania B, Duncan J, Warrington JP, Granger JP. The endothelin type a receptor as a potential therapeutic target in preeclampsia. Int J Mol Sci 2017; 18: pii: E522.
Hayman R, Warren A, Brockelsby J, Johnson I, Baker P. Plasma from women with pre-eclampsia induces an in vitro alteration in the endothelium-dependent behaviour of myometrial resistance arteries. BJOG 2000; 107: 108-115.
Poston L. Endothelial dysfunction in pre-eclampsia. Pharmacol Rep 2006; 58 Suppl: 69-74.
Schiff E, Ben-Baruch G, Peleg E, Rosenthal T, Alcalay M, Devir M, Mashiach S. Immunoreactive circulating endothelin-1 in normal and hypertensive pregnancies. Am J Obs Gynecol 1992; 166: 624-628.
Nelson SH, Steinsland OS, Wang Y, Yallampalli C, Dong YL, Sanchez JM. Increased nitric oxide synthase activity and expression in the human uterine artery during pregnancy. Circ Res 2000; 87: 406-411.
McLaughlin MK, Conrad KP. Nitric oxide biosynthesis during pregnancy: implications for circulatory changes. Clin Exp Pharmacol Physiol 1995; 22: 164-171.
Morris NH, Eaton BM, Dekker G. Nitric oxide, the endothelium, pregnancy and pre-eclampsia. Br J Obs Gynaecol 1996; 103: 4-15.
Conrad KP, Kerchner LJ, Mosher MD. Plasma and 24-h NO(x) and cGMP during normal pregnancy and preeclampsia in women on a reduced NO(x) diet. Am J Physiol 1999; 277: F48- 57.
Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA. Pathophysiology of preeclampsia: linking placental ischemia/ hypoxia with microvascular dysfunction. Microcirculation 2002; 9: 147-160.
Orabona R, Sciatti E, Vizzardi E, Bonadei I, Valcamonico A, Metra M, Frusca T. Endothelial dysfunction and vascular stiffness in women with previous pregnancy complicated by early or late pre-eclampsia. Ultrasound Obstet Gynecol 2017; 49: 116-123.